Vesper Medical raised $10.5 million in a series A round of financing.
The Mayo Clinic and AliveCor showed how AI can identify increased risks of arrhythmias and sudden cardiac death despite a normal rhythm on an EKG.
Cosmo had hoped to win FDA approval for the agent later this month but could now face a lengthy delay.
With each device and the data it generates adding to the workload of cardiac clinics, the startup sees the burden on clinics becoming too much.
Israel-based endoscope maker 3NT said it has raised most of a $15 million funding round with backing by Japanese medtech giant Hoya.
The Temasek-led series C round comes five months after Akili posted positive data from a pivotal clinical trial of its digital medicine.
The FDA approved Cook Medical’s Hemospray aerosol to control internal GI bleeding such as that caused by large ulcers, tumors or inflammatory bowel disease.
Genetic test maker Color is teaming with several healthcare institutions to provide preventive genomic testing to a wider spectrum of patients.
The initiative taps into the networks Invitae has built up to connect sponsors to patients and the clinicians responsible for their care.
Stryker has received European clearance to use its stroke device Trevo Retriever up to 24 hours after the onset of symptoms.